Tuesday January 8, 2013 0 comments
DENVER - Colorado BioScience Association has launched the Colorado BioScience Institute (The Institute) to support educational and workforce programs for the state's growing bioscience industry.
"Our board saw a need for The Institute as our industry continues to grow at 4.6 percent, outpacing the national average," said April Giles, CBSA president and CEO.
"It is expected that Colorado will need to fill 232,000 science, technology, engineering and mathematics-related jobs by 2018. CBSA's new institute is the only nonprofit in Colorado that focuses exclusively on all areas of the bioscience industry."
The lnstitute will "create a framework to train the very best young scientists and business entrepreneurs as well as assist companies with the recruitment, retention and attraction of these future bioscience employees and leaders," CBSA said.
CBSA has set a kick-off goal of $100,000 for The Institute this year. The initial $20,000 raised, including a matching gift of up to $5,000 from PhRMA, will support the launch of one of The Institute's flagship programs, the BioGENEius Challenge.
The program provides high school students with the opportunity to compete and be recognized for outstanding research in biotechnology.
The Institute's board of directors include:
- Steve Orndorff, CBSA board chair, Ariel Pharmaceuticals president and CEO;
- Derek Cole, CBSA board vice chair, ARCA Biopharma VP of investor relations and corporate communications;
- Jim Wilson, CBSA board treasurer, Ernst & Young partner;
- John Dunning, CBSA board secretary, Clarimedix Inc. president and CEO;
- Mark Spiecker, CBSA Education Executive Committee, Sharklet Technologies CEO;
- Nicole Garneau, CBSA Education Committee, curator and chair of the Health Sciences Department at Denver Museum of Nature and Science
For more information, visit www.CoBioInstitute.org.